Variants in the CYP2B6 3′UTR alter in vitro and in vivo CYP2B6 activity: potential role of microRNAs

CYP2B6*6 and CYP2B6*18 are the most clinically important variants causing reduced CYP2B6 protein expression and activity. However, these variants do not account for all variability in CYP2B6 activity. Emerging evidence has shown that genetic variants in the 3′UTR may explain variable drug response b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Pharmacol Ther
Autores principales: Burgess, Kimberly S., Ipe, Joseph, Swart, Marelize, Metzger, Ingrid F., Lu, Jessica, Gufford, Brandon T., Thong, Nancy, Desta, Zeruesenay, Gaedigk, Roger, Pearce, Robin E., Gaedigk, Andrea, Liu, Yunlong, Skaar, Todd C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871545/
https://ncbi.nlm.nih.gov/pubmed/28960269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.892
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares